Belleair Asset Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$384K Sell
320
-2
-0.6% -$2.04K 0.32% 55
2026
Q1
$296K Hold
322
0.27% 66
2025
Q4
$346K Buy
+322
New +$308K 0.33% 59

Other funds holding LLY

Belleair Asset Management's LLY Position: Q2 2026 in Review

Belleair Asset Management reduced its Eli Lilly (LLY) stake by 0.62% in Q2 2026, selling an estimated $2.04K and leaving 320 shares worth $384K. The position accounts for 0.32% of the portfolio, ranked #55.

Belleair Asset Management first reported a position in LLY in Q4 2025 and has held it in 3 quarters since. 2,861 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Belleair Asset Management held 320 shares of Eli Lilly worth $384K as of Q2 2026.
  • Belleair Asset Management sold 2 Eli Lilly shares in Q2 2026, an estimated $2.04K.
  • Eli Lilly made up 0.32% of Belleair Asset Management's portfolio in Q2 2026, its #55 holding.
  • Belleair Asset Management first reported a position in Eli Lilly in Q4 2025 and has held it in 3 quarters since.
  • 2,861 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Belleair Asset Management's 13F filing for Q2 2026, filed 15 Jul 2026.